Brain metastases in HER2-positive breast cancer: current and novel treatment strategies A Garcia-Alvarez, A Papakonstantinou, M Oliveira Cancers 13 (12), 2927, 2021 | 74 | 2021 |
Current Perspectives and Novel Strategies of NRAS-Mutant Melanoma A Garcia-Alvarez, C Ortiz, E Muñoz-Couselo OncoTargets and therapy, 3709-3719, 2021 | 32 | 2021 |
Treatment outcomes of advanced digestive well-differentiated grade 3 NETs L de Mestier, A Lamarca, J Hernando, W Zandee, T Alonso-Gordoa, ... Endocrine-Related Cancer 28 (8), 549-561, 2021 | 24 | 2021 |
What is the status of immunotherapy in thyroid neoplasms? A Garcia-Alvarez, J Hernando, A Carmona-Alonso, J Capdevila Frontiers in endocrinology 13, 929091, 2022 | 20 | 2022 |
Drug development in neuroendocrine tumors: what is on the horizon? A Garcia-Alvarez, J Hernando Cubero, J Capdevila Current Treatment Options in Oncology 22, 1-19, 2021 | 9 | 2021 |
Phase II study of durvalumab plus total neoadjuvant therapy (TNT) in locally advanced rectal cancer: The GEMCAD-1703 DUREC trial. J Capdevila, I Macias Declara, MC Riesco Martinez, J Maurel, ... Journal of Clinical Oncology 38 (15_suppl), TPS4122-TPS4122, 2020 | 9 | 2020 |
What is the status of immunotherapy in neuroendocrine neoplasms? A Garcia-Alvarez, JH Cubero, J Capdevila Current Oncology Reports 24 (4), 451-461, 2022 | 4 | 2022 |
Aggressive pituitary macroadenoma treated with capecitabine and temozolomide chemotherapy combination in a patient with Nelson’s syndrome: a case report O Mirallas, F Filippi-Arriaga, I Hernandez Hernandez, A Aubanell, ... Frontiers in Endocrinology 12, 731631, 2021 | 4 | 2021 |
Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin: the phase II DUNE trial (GETNE 1601) J Capdevila, J Hernando, A Teule, C Lopez, R Garcia-Carbonero, ... | 2 | 2022 |
Aggressive Pituitary Macroadenoma Treated With Capecitabine and Temozolomide Chemotherapy Combination in a Patient With Nelson’s Syndrome: A Case Report O Mirallas Viñas, MFE Filippi Arriaga, I Hernández Hernández, ... Frontiers Media, 2021 | | 2021 |